Avanir Pharmaceuticals, Drug Royalty deal

AVN sold DRI a portion of its North American royalty stream on cold sore drug Abreva docosanol 10% cream. AVN retains rights to 50% of royalties earned on sales of Abreva in excess of $62 million a y...